United States - English - NLM (National Library of Medicine)

belux uk medical technology ltd - alcohol (unii: 3k9958v90m) (alcohol - unii:3k9958v90m) - antiseptic to help decrease germs on the skin that could cause disease. recommended for repeated use. irritation or redness develops. condition persists for more than 72 hours.

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

torbet laboratories ltd - activated charcoal; magnesium hydroxide - oral tablet - 100mg ; 100mg

United States - English - NLM (National Library of Medicine)

intelligent skin care inc. - active ingredients purpose, octyl methoxycinnamate 6% sunscreen, octocrylene .60%, oxybenzone .50%, titanium dioxide .41% - purpose sunscreen use helps prevent sunburn

United States - English - NLM (National Library of Medicine)

intelligent skin care inc. - active ingredients purpose, octyl methoxycinnamate 5% sunscreen, titanium dioxide 6.13%, octocrylene .8% - use helps prevent sunburn purpose helps prevent sunburn

United States - English - NLM (National Library of Medicine)

intelligent skin care inc. - active ingredients purpose, octyl methoxycinnamate 6% sunscreen, octocrylene .60%, oxybenzone .50%, titanium dioxide .41% - purpose sunscreen use helps prevent sunburn

United States - English - NLM (National Library of Medicine)

alk-abello a s - ambrosia artemisiifolia pollen (unii: k20y81aco3) (ambrosia artemisiifolia pollen - unii:k20y81aco3) - ambrosia artemisiifolia pollen 12 [amb'a'1'u] - ragwitek® is an allergen extract indicated as immunotherapy for the treatment of short ragweed pollen-induced allergic rhinitis, with or without conjunctivitis, confirmed by positive skin test or in vitro testing for pollen-specific ige antibodies for short ragweed pollen. ragwitek is approved for use in persons 5 through 65 years of age. ragwitek is not indicated for the immediate relief of allergic symptoms. ragwitek is contraindicated in patients with: - severe, unstable or uncontrolled asthma - a history of any severe systemic allergic reaction - a history of any severe local reaction after taking any sublingual allergen immunotherapy - a history of eosinophilic esophagitis - hypersensitivity to any of the inactive ingredients [gelatin, mannitol, and sodium hydroxide] contained in this product [see description ( 11 )]. risk summary all pregnancies have a risk of birth defect, loss, or other adverse outcomes. in the u.s. general population, the estimated background risk of major birth defects and miscarr

United States - English - NLM (National Library of Medicine)

alk-abello a s - phleum pratense pollen (unii: 65m88rw2eg) (phleum pratense pollen - unii:65m88rw2eg) - phleum pratense pollen 2800 [bau] -       grastek®  is an allergen extract indicated as immunotherapy for the treatment of grass pollen-induced allergic rhinitis with or without conjunctivitis confirmed by positive skin test or in vitro  testing for pollen-specific ige antibodies for timothy grass or cross-reactive grass pollens. grastek is approved for use in persons 5 through 65 years of age.       grastek is not indicated for the immediate relief of allergic symptoms.       grastek is contraindicated in patients with: - severe, unstable or uncontrolled asthma  - a history of any severe systemic allergic reaction - a history of any severe local reaction after taking any sublingual allergen immunotherapy - a history of eosinophilic esophagitis - hypersensitivity to any of the inactive ingredients [gelatin, mannitol and sodium hydroxide] contained in this product [ s ee description ( 11 )].       risk summary       all pregnancies have a risk of birth defect, loss, or other adverse outcomes. in the u.s. general population, the estimated b